CompletedPhase 2NCT00093418
S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Harry Erba, MDSWOG Cancer Research Network
- Intervention
- tipifarnib(drug)
- Enrollment
- 296 enrolled
- Eligibility
- 70 years · All sexes
- Timeline
- 2004
Study locations (1)
- Southwest Oncology Group, San Antonio, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00093418 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.